Stokes Capital Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$690K Buy
5,373
+1,275
+31% +$149K 0.15% 70
2026
Q1
$493K Buy
4,098
+1,838
+81% +$212K 0.11% 69
2025
Q4
$238K Buy
+2,260
New +$212K 0.05% 76
2025
Q1
Sell
-44,324
Closed -$4.41M 76
2024
Q4
$4.41M Buy
44,324
+1,571
+4% +$162K 1.14% 43
2024
Q3
$4.86M Buy
42,753
+3,547
+9% +$421K 1.24% 42
2024
Q2
$4.85M Buy
39,206
+6,360
+19% +$819K 1.35% 40
2024
Q1
$4.33M Buy
32,846
+1,210
+4% +$149K 1.26% 41
2023
Q4
$3.45M Buy
31,636
+364
+1% +$37.8K 1.09% 43
2023
Q3
$3.22M Sell
31,272
-26
-0.1% -$2.8K 1.12% 44
2023
Q2
$3.61M Sell
31,298
-1,397
-4% -$159K 1.22% 40
2023
Q1
$3.48M Sell
32,695
-703
-2% -$75.9K 1.18% 43
2022
Q4
$3.71M Sell
33,398
-2,877
-8% -$294K 1.28% 39
2022
Q3
$3.12M Sell
36,275
-13,718
-27% -$1.22M 1.16% 40
2022
Q2
$4.56M Sell
49,993
-1,618
-3% -$143K 1.59% 35
2022
Q1
$4.24M Buy
51,611
+2,964
+6% +$234K 1.23% 41
2021
Q4
$3.73M Sell
48,647
-945
-2% -$75.3K 1.11% 43
2021
Q3
$3.73M Sell
49,592
-779
-2% -$59.2K 1.2% 44
2021
Q2
$3.92M Sell
50,371
-471
-0.9% -$35K 1.28% 41
2021
Q1
$3.74M Buy
50,842
+4,145
+9% +$306K 1.53% 38
2020
Q4
$3.65M Buy
46,697
+3,835
+9% +$293K 1.59% 35
2020
Q3
$3.39M Buy
42,862
+3,174
+8% +$249K 1.63% 30
2020
Q2
$2.93M Buy
+39,688
New +$2.99M 1.55% 33

Other funds holding MRK

Stokes Capital Advisors's MRK Position: Q2 2026 in Review

Stokes Capital Advisors increased its Merck (MRK) stake by 31% in Q2 2026, buying an estimated $149K and bringing the position to 5,373 shares worth $690K. The position accounts for 0.15% of the portfolio, ranked #70.

Stokes Capital Advisors first reported a position in MRK in Q2 2020 and has held it in 22 quarters since. The position peaked at $4.86M in Q3 2024. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Stokes Capital Advisors held 5,373 shares of Merck worth $690K as of Q2 2026.
  • Stokes Capital Advisors bought 1,275 Merck shares in Q2 2026, an estimated $149K.
  • Merck made up 0.15% of Stokes Capital Advisors's portfolio in Q2 2026, its #70 holding.
  • Stokes Capital Advisors first reported a position in Merck in Q2 2020 and has held it in 22 quarters since.
  • Stokes Capital Advisors's Merck position peaked at $4.86M in Q3 2024.
  • 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Stokes Capital Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.